View by Specialty

Trending

Stomach
September 27, 2024
5 min read
Save

Q&A: What is driving ‘disturbing’ rise in metastatic stomach cancer in young adults?

Neurology News

SPONSORED CONTENT
Save
SPONSORED CONTENT
July 15, 2022
2 min read
Save

Plasma biomarkers can be used to detect tau pathology in Down syndrome

Plasma biomarkers can be used to detect tau pathology in Down syndrome

Plasma p-tau217 proved an accurate blood-based biomarker of both tau and amyloid-beta pathological brain alterations for those with Down syndrome and may be used alone or with age as a covariate, per a study published in JAMA Neurology.

SPONSORED CONTENT
July 15, 2022
1 min read
Save

Nonalcoholic fatty liver disease linked to increased risk for dementia

Nonalcoholic fatty liver disease linked to increased risk for dementia

Patients with nonalcoholic fatty liver disease had an increased risk for dementia, with stronger risk existing for those with comorbid heart disease or stroke, according to a study published in Neurology.

Trending

Stomach
September 27, 2024
5 min read
Save

Q&A: What is driving ‘disturbing’ rise in metastatic stomach cancer in young adults?

SPONSORED CONTENT
July 15, 2022
2 min read
Save

Flu-like illness confers stroke risk in younger patients; vaccination may offer protection

Flu-like illness confers stroke risk in younger patients; vaccination may offer protection

Influenza-like illness conferred increased odds of 30-day stroke in young patients, but vaccination was associated with lower risk compared with non-vaccination, according to data published in Stroke.

SPONSORED CONTENT
July 14, 2022
1 min read
Save

Ketamine effective treatment for neonatal, pediatric epilepsy

Ketamine effective treatment for neonatal, pediatric epilepsy

Treatment with ketamine significantly improved seizure occurrence related to refractory status epilepticus in both neonates and children, according to results of a study published in Neurology.

SPONSORED CONTENT
July 14, 2022
1 min read
Save

Labcorp blood test identifies signs of neurodegenerative disease

Labcorp blood test identifies signs of neurodegenerative disease

Labcorp Diagnostics announced the launch of the first widely accessible blood test that provides direct evidence of neurodegeneration and neuronal injury.

SPONSORED CONTENT
July 13, 2022
1 min read
Save

Erythropoietin fails to lower death in neonates with neurologic condition

Erythropoietin fails to lower death in neonates with neurologic condition

High-dose erythropoietin failed to lower the risk for death among newborns undergoing therapeutic hypothermia for neonatal hypoxic ischemic encephalopathy, according to study findings published in The New England Journal of Medicine.

SPONSORED CONTENT
July 13, 2022
2 min read
Save

Eptinezumab reduced migraine effects for adults with previous treatment failures

Eptinezumab reduced migraine effects for adults with previous treatment failures

For adults with migraine and repeated preventive treatment failures, eptinezumab produced significant reductive effects compared with placebo, along with acceptable safety and tolerability, per a study published in Lancet Neurology.

SPONSORED CONTENT
July 13, 2022
1 min read
Save

Decompressive craniectomy linked to lower mortality, improved recovery

Decompressive craniectomy linked to lower mortality, improved recovery

Patients with posttraumatic refractory intracranial hypertension treated with decompressive craniectomy showed reduced mortality and improved recovery at 24 months compared with standard care, per a study published in JAMA Neurology.

SPONSORED CONTENT
July 13, 2022
1 min read
Save

FDA grants fast track, orphan drug designations to glioblastoma therapy

FDA grants fast track, orphan drug designations to glioblastoma therapy

The FDA granted fast track and orphan drug designations to Alpheus Medical’s CV-01 delivery of sonodynamic therapy for treatment of recurrent glioblastoma.

SPONSORED CONTENT
July 12, 2022
1 min read
Save

FDA places hold on phase 2/3 clinical trial of stroke therapy

FDA places hold on phase 2/3 clinical trial of stroke therapy

Biopharmaceutical company DiaMedica Therapeutics Inc. announced that the FDA placed a clinical hold on its phase 2/3 ReMEDy2 trial of a synthetic protein therapy for treatment of acute ischemic stroke.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails